Lenz Therapeutics Inc (LENZ) returns
Lenz Therapeutics returns over 5 years
$1,000 invested in Lenz Therapeutics five years ago was worth $47.59 at the close on October 30, 2026, with dividends reinvested: an average return of -45.6% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -20.6% | — | $794.27 | -0.9% |
| 3 months | -47.0% | — | $529.51 | +2.1% |
| Year to date | -80.9% | — | $190.63 | +11.7% |
| 1 year | -90.0% | — | $100.13 | +12.4% |
| 3 years | -74.5% | -36.6% | $254.76 | +88.5% |
| 5 years | -95.2% | -45.6% | $47.59 | +76.0% |
Lenz Therapeutics return by calendar year
| Year | LENZ | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -80.9% | +11.7% | -92.6% |
| 2025 | -44.6% | +17.7% | -62.3% |
| 2024 | +119.1% | +24.9% | +94.2% |
| 2023 | -21.1% | +26.2% | -47.3% |
| 2022 | -73.3% | -18.2% | -55.1% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Lenz Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.